Bas Trietsch Discusses Successes so Far Using Organ on a Chip Technology for Bio/Pharmaceuticals (INTERPHEX 2023)

Article

Bas Trietsch, chief technology officer, MIMETAS, discusses the successes he's encountered so far using organ on a chip technology in bio/pharmaceutical research.

Bas Trietsch, chief technology officer, MIMETAS, and one of the INTERPHEX Keynote speakers in the Organ on a Chip for Pharmaceutical Development session, discusses the successes his company has encountered so far using organ on a chip technology in bio/pharmaceutical research.

For more INTERPHEX 2023 video content, check this page for updates.

Recent Videos
Behind the Headlines episode 5
Buy, Sell, Hold: Cell and Gene Therapy
Buy, Sell, Hold: Cell and Gene Therapy
Buy, Sell, Hold: Cell and Gene Therapy
Related Content
Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com

Top 10 Feature Articles of 2024

Susan Haigney
December 31st 2024
Article

The BioPharm International® editors present our most popular technical articles from 2024.

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com

Top 10 Video Interviews of 2024

Susan Haigney
December 30th 2024
Article

The BioPharm International editors present our most popular video interviews from 2024.

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com

FDA Approves First Generic Version of a GLP-1 Injection for Type 2 Diabetes

Feliza Mirasol
December 26th 2024
Article

The approval of Hikma Pharmaceuticals’ liraglutide injection marks the first generic version of Victoza, a GLP-1 receptor agonist.

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com

WHO Gives Update on COVID-19 Vaccines

Susan Haigney
December 25th 2024
Article

Pointing to the continued circulation and evolution of COVID-19, WHO published a statement on the COVID-19 vaccine antigen composition to respond to variants of the virus.

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com

Personal Data in European Medicine Regulation

Susan Haigney
December 24th 2024
Article

EMA and HMA have published revised guidelines on identification of commercially confidential information and personal data used in marketing authorization applications.

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com

EMA Gives Recommendations Including Several Orphan Drugs for Approval in December

Susan Haigney
December 17th 2024
Article

EMA's committee gave recommendations for marketing authorization of 17 drugs in December, which include therapies for rare heart conditions, anemia, and liver disease.

© 2025 MJH Life Sciences

All rights reserved.